214 related articles for article (PubMed ID: 25643152)
1. Alpha-enolase is upregulated on the cell surface and responds to plasminogen activation in mice expressing a ∆133p53α mimic.
Sawhney S; Hood K; Shaw A; Braithwaite AW; Stubbs R; Hung NA; Royds JA; Slatter TL
PLoS One; 2015; 10(2):e0116270. PubMed ID: 25643152
[TBL] [Abstract][Full Text] [Related]
2. Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.
Slatter TL; Hung N; Bowie S; Campbell H; Rubio C; Speidel D; Wilson M; Baird M; Royds JA; Braithwaite AW
Cell Death Dis; 2015 Jun; 6(6):e1783. PubMed ID: 26068791
[TBL] [Abstract][Full Text] [Related]
3. Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.
Hsiao KC; Shih NY; Fang HL; Huang TS; Kuo CC; Chu PY; Hung YM; Chou SW; Yang YY; Chang GC; Liu KJ
PLoS One; 2013; 8(7):e69354. PubMed ID: 23894455
[TBL] [Abstract][Full Text] [Related]
4. The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2.
Roth I; Campbell H; Rubio C; Vennin C; Wilson M; Wiles A; Williams G; Woolley A; Timpson P; Berridge MV; Fleming N; Baird M; Braithwaite AW
Oncogene; 2016 Sep; 35(38):4981-9. PubMed ID: 26996665
[TBL] [Abstract][Full Text] [Related]
5. α-Enolase Causes Proinflammatory Activation of Pulmonary Microvascular Endothelial Cells and Primes Neutrophils Through Plasmin Activation of Protease-Activated Receptor 2.
Bock A; Tucker N; Kelher MR; Khan SY; Gonzalez E; Wohlauer M; Hansen K; Dzieciatkowska M; Sauaia A; Banerjee A; Moore EE; Silliman CC
Shock; 2015 Aug; 44(2):137-42. PubMed ID: 25944790
[TBL] [Abstract][Full Text] [Related]
6. alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis.
Agarwal S; Kulshreshtha P; Bambah Mukku D; Bhatnagar R
Biochim Biophys Acta; 2008; 1784(7-8):986-94. PubMed ID: 18456007
[TBL] [Abstract][Full Text] [Related]
7. α-Enolase, a multifunctional protein: its role on pathophysiological situations.
Díaz-Ramos A; Roig-Borrellas A; García-Melero A; López-Alemany R
J Biomed Biotechnol; 2012; 2012():156795. PubMed ID: 23118496
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
[TBL] [Abstract][Full Text] [Related]
9. The Mycoplasma gallisepticum α-enolase is cell surface-exposed and mediates adherence by binding to chicken plasminogen.
Chen H; Yu S; Shen X; Chen D; Qiu X; Song C; Ding C
Microb Pathog; 2011 Oct; 51(4):285-90. PubMed ID: 21664449
[TBL] [Abstract][Full Text] [Related]
10. The role of an enolase-related molecule in plasminogen binding to cells.
Redlitz A; Fowler BJ; Plow EF; Miles LA
Eur J Biochem; 1995 Jan; 227(1-2):407-15. PubMed ID: 7851415
[TBL] [Abstract][Full Text] [Related]
11. The human ENO1 gene product (recombinant human alpha-enolase) displays characteristics required for a plasminogen binding protein.
Andronicos NM; Ranson M; Bognacki J; Baker MS
Biochim Biophys Acta; 1997 Jan; 1337(1):27-39. PubMed ID: 9003434
[TBL] [Abstract][Full Text] [Related]
12. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
13. Enolase as a plasminogen binding protein in Leishmania mexicana.
Vanegas G; Quiñones W; Carrasco-López C; Concepción JL; Albericio F; Avilán L
Parasitol Res; 2007 Nov; 101(6):1511-6. PubMed ID: 17653767
[TBL] [Abstract][Full Text] [Related]
14. Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform.
Slatter TL; Hung N; Campbell H; Rubio C; Mehta R; Renshaw P; Williams G; Wilson M; Engelmann A; Jeffs A; Royds JA; Baird MA; Braithwaite AW
Blood; 2011 May; 117(19):5166-77. PubMed ID: 21411755
[TBL] [Abstract][Full Text] [Related]
15. [Enolase on the surface of prockaryotic and eukaryotic cells is a receptor for human plasminogen].
Seweryn E; Pietkiewicz J; Szamborska A; Gamian A
Postepy Hig Med Dosw (Online); 2007 Nov; 61():672-82. PubMed ID: 18033204
[TBL] [Abstract][Full Text] [Related]
16. Enolase of Mycobacterium tuberculosis is a surface exposed plasminogen binding protein.
Rahi A; Matta SK; Dhiman A; Garhyan J; Gopalani M; Chandra S; Bhatnagar R
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3355-3364. PubMed ID: 27569900
[TBL] [Abstract][Full Text] [Related]
17. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.
Miles LA; Dahlberg CM; Plescia J; Felez J; Kato K; Plow EF
Biochemistry; 1991 Feb; 30(6):1682-91. PubMed ID: 1847072
[TBL] [Abstract][Full Text] [Related]
18. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
López-Alemany R; Suelves M; Muñoz-Cánoves P
Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
[TBL] [Abstract][Full Text] [Related]
19. Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity.
Gentile F; Pizzimenti S; Arcaro A; Pettazzoni P; Minelli R; D'Angelo D; Mamone G; Ferranti P; Toaldo C; Cetrangolo G; Formisano S; Dianzani MU; Uchida K; Dianzani C; Barrera G
Biochem J; 2009 Aug; 422(2):285-94. PubMed ID: 19508232
[TBL] [Abstract][Full Text] [Related]
20. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
Cappello P; Tomaino B; Chiarle R; Ceruti P; Novarino A; Castagnoli C; Migliorini P; Perconti G; Giallongo A; Milella M; Monsurrò V; Barbi S; Scarpa A; Nisticò P; Giovarelli M; Novelli F
Int J Cancer; 2009 Aug; 125(3):639-48. PubMed ID: 19425054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
